INTERNATIONAL PATENT: WUXI BIOLOGICS (SHANGHAI) CO., LTD., WUXI BIOLOGICS IRELAND LIMITED FILES APPLICATION FOR "GPC3 ANTIBODY-DRUG CONJUGATES AND USE THEREOF"

GENEVA, June 16 -- WUXI BIOLOGICS (SHANGHAI) CO., LTD. (No. 299 Fute Zhong RoadPudong New Area, Shanghai 200131), WUXI BIOLOGICS IRELAND LIMITED (Mullagharlin, Dundalk, Co Louth A91 X56F) filed a patent application (PCT/CN2024/137386) for "GPC3 ANTIBODY-DRUG CONJUGATES AND USE THEREOF" on Dec 06, 2024. With publication no. WO/2025/119322, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HU, Yaohua (No. 299 Fute Zhong RoadPudong New Area, Shanghai 200131), WANG, Xia (No. 299 Fute Zhong RoadPudong New Area, Shanghai 200131),...